QL Block in Laparoscopic Myomectomy

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorJoseph Findley MD

About this trial

This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.

Eligibility criteria

Qualifiers

Presence of uterine fibroids requiring surgical excision with preservation of the uterus

Stated willingness to comply with all study procedures and availability for the duration of the study

Provision of signed and dated informed consent form

Disqualifiers

Pre-existing diagnoses of anxiety or depression

Pre-existing coagulopathies

Pre-existing neuropathic or chronic pelvic pain

Chronic opioid use

Trial design

Treatments tested in this trial

  • Bupivacain
  • Saline

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Joseph Findley MD

Lead sponsor

University Hospitals Cleveland Medical Center

Sponsor institution